In CRC, these analyses identified crucial signaling pathways, such as WNT, RAS-MAPK, PI3K, TGF-β, and p53, and recurrent mutations in key genes such as APC, KRAS, TP53, and PIK3CA [3,14]. Here, KRAS is linked to colorectal carcinoma.